Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Argentína

13 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

• No phaseTaking people
  Study of Clinical and Patient-reported Outcomes in Adults With Moderate to Severe COPD Treated With Breztri/Trixeo

  Where

  Buenos Aires, La Plata, Mar del Plata, Mendoza

  Életkor

  30 év to 80 év

  People

  1400 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07069829
• 2. fázisTaking people
  A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  Where

  Buenos Aires, Mendoza, Río Cuarto, Santa Rosa

  Életkor

  40 év to 75 év

  People

  606 worldwide

  Run by

  Eli Lilly and Company

  See details and how to joinNCT07759245 · EU 2026-525480-41-00
• 2. fázisTaking people
  A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  Where

  Alberdi, CABA, Ciudad Autónoma de Bs. As., Ciudad de Buenos Aires, Mar del Plata, Mendoza, Ranelagh, Rosario, San Miguel de Tucumán

  Életkor

  40 év and over

  People

  987 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07082738
• 3. fázisTaking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  Where

  Berazategui, Buenos Aires, Córdoba, Mendoza, Santa Fe

  Életkor

  40 év to 80 év

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190222 · EU 2024-518213-25-00
• 2. fázisTaking people
  A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

  Where

  Bahía Blanca, Buenos Aires, Córdoba, Mendoza, Quilmes, Rosario, San Miguel de Tucumán, Santa Fe

  Életkor

  40 év to 80 év

  People

  105 worldwide

  Run by

  Windward Bio

  See details and how to joinNCT07646587
• 2/3. fázisTaking people
  A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  Where

  Ciudad Autonoma de Buenos Aires, Córdoba, Mar del Plata, Mendoza, Rosario

  Életkor

  35 év to 80 év

  People

  1156 worldwide

  Run by

  Pfizer

  See details and how to joinNCT07363694 · EU 2024-518587-12-00
• 4. fázisTaking people
  A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

  Where

  Buenos Aires, San Miguel de Tucumán

  Életkor

  40 év to 85 év

  People

  218 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07053423
• 3. fázisTaking people
  Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  Where

  Buenos Aires, La Plata, Lobos, Rosario, San Miguel de Tucumán

  Életkor

  40 év to 80 év

  People

  942 worldwide

  Run by

  Sanofi

  See details and how to joinNCT07190209 · EU 2024-518016-39-00
• No phaseTaking people
  Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis

  Where

  Buenos Aires, Medoza

  Életkor

  18 év and over

  People

  600 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT07245576
• 3. fázisTaking people
  A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  Where

  Alberdi, Buenos Aires, Ciudad de Buenos Aires, Florida, La Plata, Mar del Plata, Mendoza, Quilmes, Rosario, San Fernando, San Juan Bautista

  Életkor

  40 év to 80 év

  People

  990 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06878261 · EU 2024-517457-27-00
• 3. fázisTaking people
  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  Where

  Buenos Aires, Ciudad Autonoma de Bueno, La Plata, Mendoza, Paraná, Rosario, San Juan Bautista, San Miguel de Tucumán

  Életkor

  40 év to 80 év

  People

  981 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT06959095 · EU 2024-520418-22-00
• 3. fázisTaking people
  Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  Where

  Berazategui, Buenos Aires, Córdoba, Lobos, Quilmes, Rosario, Rosario Provincia de Santa FE, San Miguel de Tucumán, Santa Fe, Sante Fe

  Életkor

  40 év to 80 év

  People

  961 worldwide

  Run by

  GlaxoSmithKline

  See details and how to joinNCT06961214 · EU 2024-520417-41-00
• 3. fázisTaking people
  A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  Where

  Buenos Aires, CABA, Ciudad Autónoma de Bs. As., Ciudad de Buenos Aires, Florida, Mar del Plata, Mendoza, Ranelagh, Rosario, San Fernando, San Juan Bautista, San Miguel de Tucumán

  Életkor

  40 év to 80 év

  People

  5250 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT06283966 · EU 2023-507407-59-00